3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Myeloid
1
Classical hematology
1
Conditions
Stomach Neoplasms
14
Prostatic Neoplasms
13
Colorectal Neoplasms
13
Neoplasms
12
Pancreatic Neoplasms
10
Endometrial Neoplasms
9
Carcinoma, Non-Small-Cell Lung
9
Breast Neoplasms
9
Lung Neoplasms
7
Colonic Neoplasms
7
Neoplasm Metastasis
6
Carcinoma, Hepatocellular
6
Oropharyngeal Neoplasms
5
Multiple Myeloma
5
Mouth Neoplasms
5
Lymphoma, Large B-Cell, Diffuse
5
Sarcoma
4
Recurrence
4
Rectal Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Esophageal Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Melanoma
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Mantle-Cell
3
Lymphoma, Follicular
3
Leukemia, Myeloid, Acute
3
Head and Neck Neoplasms
3
Gastrointestinal Stromal Tumors
3
Interventions
eltrombopag
9
avatrombopag
6
Platelet Transfusion
6
romiplostim
4
Tranexamic Acid
3
Radiotherapy
3
Cytarabine
3
oprelvekin
2
hetrombopag
2
Tretinoin
2
Peripheral Blood Stem Cell Transplantation
2
Filgrastim
2
Cyclophosphamide
2
Carboplatin
2
Busulfan
2
Amplified Fragment Length Polymorphism Analysis
2
sodium thiosulfate
1
siltuximab
1
raltitrexed
1
pegfilgrastim
1
ofatumumab
1
niraparib
1
leridistim
1
fludarabine phosphate
1
fludarabine
1
etoposide phosphate
1
apixaban
1
Vorinostat
1
Vitamin B 12
1
Transplantation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Thrombocytopenia
×
Observation
×
Clear all
NCT07108023
2025-08-06
EHPVO-HEM
Assiut University
Not yet recruiting
115 enrolled